SCP Vitalife Partners II LP is 10% Owner at Recro Pharma, Inc. (REPH). They have made 17 open-market trades across 2 companies since 2015, most recently 2020-12-22.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 82% | 53% | 59% |
| Avg Move | -2.5% | -1.7% | -6.3% |
| Scored | 17 | 17 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REPH | SELL | 2020-12-22 | 2020-12-28 | $3.17 | $357K | -0.3% | +5.3% | -6.7% |
| REPH | SELL | 2020-12-18 | 2020-12-22 | $3.03 | $113K | -5.8% | +12.8% | +12.5% |
| REPH | SELL · 10b5-1 | 2018-01-04 | 2018-01-08 | $8.84 | $42K | +3.1% | -6.7% | +20.6% |
| REPH | SELL | 2018-01-02 | 2018-01-04 | $8.88 | $689K | +1.3% | -9.1% | +25.0% |
| REPH | SELL | 2017-12-28 | 2018-01-02 | $9.27 | $338K | -1.3% | -3.3% | +20.4% |
| REPH | SELL | 2017-12-26 | 2017-12-28 | $9.55 | $206K | -8.6% | -7.7% | +13.7% |
| REPH | SELL | 2017-03-14 | 2017-03-20 | $8.00 | $1.1M | -0.6% | +0.8% | -18.9% |
| REPH | SELL | 2017-02-17 | 2017-03-20 | $7.59 | $152K | -0.6% | +0.8% | -18.9% |
| REPH | SELL | 2017-02-14 | 2017-03-20 | $7.89 | $190K | -0.6% | +0.8% | -18.9% |
| REPH | SELL | 2017-02-13 | 2017-02-15 | $7.97 | $127K | -1.5% | +1.9% | +7.1% |
| RWLK | SELL | 2016-08-15 | 2016-08-17 | $6.37 | $477K | -6.3% | -6.5% | -55.1% |
| RWLK | SELL | 2016-05-31 | 2016-06-02 | $7.74 | $66K | -16.6% | -21.4% | -25.3% |
| RWLK | SELL | 2016-05-25 | 2016-05-27 | $8.69 | $352K | -15.0% | -25.4% | -28.6% |
| REPH | SELL | 2016-05-23 | 2016-05-25 | $6.30 | $47K | +11.2% | +3.0% | +27.5% |
| REPH | SELL | 2016-05-19 | 2016-05-23 | $6.45 | $121K | +33.3% | +24.5% | +35.2% |
| REPH | SELL | 2015-11-30 | 2015-12-01 | $9.00 | $4K | -10.2% | -1.5% | -24.3% |
| REPH | SELL | 2015-11-25 | 2015-11-30 | $9.00 | $102K | -10.2% | -1.5% | -24.3% |
| REPH | SELL | 2015-11-23 | 2015-11-25 | $9.00 | $118K | -10.2% | -1.5% | -26.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.